Here, we found that high levels of heparanase in stage I breast cancer (with tumors smaller than 2 cm and without lymph node involvement) correlates with a 4.5-fold increased risk of disease recurrence (Figure 2B). This evidence concerns the gene HPSE and breast carcinoma.